James S. Mahan III, Chief Executive Officer of Live Oak Bancshares (NASDAQ:LOB), carried out a series of stock sales through the James S. Mahan Revocable Trust on February 4 and 5, 2026, disposing of a combined 20,000 shares of the company’s voting common stock for approximately $821,072.
The transactions were executed at prices spanning $40.1332 to $42.4358 per share and were split across multiple trades. On February 4, Mahan sold 9,760 shares at a weighted average price of $41.8825, with trade prices ranging from $41.26 to $42.21. He also sold 240 shares that day at a weighted average price of $42.4358, within a $42.38 to $42.50 band. The following day, February 5, he sold 9,350 shares at a weighted average of $40.1332, in a range of $39.70 to $40.63, and an additional 650 shares at a weighted average price of $41.3377, in a $41.03 to $41.68 range.
These sales were carried out pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on August 27, 2025.
Ownership records following the transactions show significant holdings across related trusts and entities. The James S. Mahan Revocable Trust held 3,047,844 shares; the Marguerite D. Mahan Revocable Trust held 3,032,547 shares; the 2021 Chip Mahan Family and Charitable Trust held 127,167 shares; the 2021 Peggy Mahan Family Trust held 127,167 shares; and Peapod II, LLC held 140,150 shares.
The sales occurred amid a period of strong price performance for Live Oak Bancshares. According to InvestingPro data, the stock has climbed 33% over the past six months and was trading at $40.83 at the time of the report.
Separately, Live Oak Bancshares reported robust fourth-quarter results for 2025. The bank posted earnings per share of $0.95, a 66.67% surprise versus the forecasted $0.57. Revenue for the quarter reached $172.91 million, exceeding projections by 14.27%.
Following the quarterly results, Keefe, Bruyette & Woods increased its price target for Live Oak Bancshares to $146 from $132 and maintained an Outperform rating on the stock.
Context
The sales were carried out under the terms of the Rule 10b5-1 plan adopted in August 2025. The company’s recent quarterly performance and the analyst price-target revision are noted developments that coincide with the insider transactions.
Disclosure
No additional disclosures are provided in the article text.